Teva Pharmaceutical Industries LtdTEVA:TLV

18,770
10.00 / 0.05%
451.40k
27.77%
0.6636
Latest price in ILAToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Jul 23 2014 14:43 BST.

Summary

As of last trade Teva Pharmaceutical Industries Ltd (TEVA:TLV) traded at 18,770, 0.58% below its 52-week high of 18,880, set on Jul 03, 2014.

52-week range
Today
12,800
Nov 05 2013
18,880
Jul 03 2014
Markit short selling activity
Low
Medium
High
Open18,720
Day high18,840
Day low18,640
Bid18,760
Offer18,790
Previous close18,760
Average volume310.11k
Shares outstanding951.29m
Free float936.88m
P/E (TTM)36.81
Market cap178.21bn ILS
EPS (TTM)5.09 ILS
Annual div (TTM)401.20 ILS
Annual div yield (TTM)2.14%
Div ex-dateMay 20 2014
Div pay-dateJun 02 2014
Data delayed at least 20 minutes, as of Jul 23 2014 14:43 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Teva Pharmaceutical Industries Ltd+0.37%+2.91%+19.94%+27.77%-2.95%
TASE TA-100 IDX-0.43%-0.78%+2.31%+12.90%+47.63%
IL/HEALTH CARE+0.32%+2.77%+18.28%+21.70%--
IL/PHARMACEUTICALS+0.32%+2.77%+18.28%+21.70%--
Data delayed at least 20 minutes, as of Jul 23 2014 14:43 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.